Med24
Lääketieteellinen tutkimus 6. 10. 2026 • 2 min read • laaketieteen-uutiset

Lääkinnällinen cannabis parantaa nivelreumaa – pitkäaikaisia havaintoja UK:n rekisteristä

Uudet havainnot UK:n lääkinnällisen kannabiksen rekisteristä viittaavat siihen, että lääkinnällisen kannabiksen käyttö voi tuottaa pitkäaikaisia paranemisen merkkejä nivelreuman potilailla. Tutkimus seurasi 192 potilasta, joilla oli nivelreumasta johtuva kipu ja arvioi potilaiden raportoimia tuloksia useiden kuukausien välein.

Lääkinnällinen cannabis parantaa nivelreumaa – pitkäaikaisia havaintoja UK:n rekisteristä

Observational data from the UK Medical Cannabis Registry indicates sustained improvements in patients with inflammatory arthritis using medical cannabis preparations. The study assessed 192 patients experiencing arthritis-associated pain, monitoring changes in patient-reported outcomes at intervals from one to twenty-four months. Improvements were noted in pain, sleep quality, and overall quality of life for participants. Specifically, significant reductions in pain levels were observed, alongside improvements in sleep quality and overall quality of life.

Researchers reported marked improvements in pain, sleep quality, and overall quality of life. Adverse events associated with cannabis therapy were generally mild, including fatigue and dry mouth. Fewer than 15 percent of participants reported adverse events throughout the study period, suggesting that cannabis-based medicinal products were well-tolerated. This low incidence of adverse events further supports the potential benefits of medical cannabis in managing this chronic condition.

These findings support ongoing evaluation of cannabis-based medicinal preparations for inflammatory arthritis-associated chronic pain. Additional observational studies have reported benefits for conditions including treatment-resistant epilepsy, cancer-related pain, anxiety, and various inflammatory and neurological disorders.

Sponsored content

Further research, specifically randomized clinical trials, is recommended to fully evaluate the efficacy and safety of cannabis-based medicinal preparations for inflammatory arthritis.

Original Scientific Source
laaketieteen-uutiset
View Original Source
Lääketieteellinen vastuuvapauslauseke Kaikki tämän sivuston laskelmat, suositukset ja tulkinnat ovat ainoastaan suuntaa-antavia ja koulutuksellisia. Ne eivät korvaa ammattimaista lääkärintarkastusta, diagnoosia tai hoitoa. Käänny aina lääkärin puoleen terveysasioissa.

Recommended Medical News

All news →
Advertisement